Northwest Biotherapeutics Inc (NASDAQ:NWBO)

12.00
Delayed Data
As of 3:59pm ET
 +1.01 / +9.19%
Today’s Change
3.79
Today|||52-Week Range
12.55
+124.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.00872.0K194.0K
 
 
 
Depreciation And Amortization3.0K346.0K--3.0K
 
 
 
 
 
Operating ExpensesGross Income-3.0K-346.0K872.0K191.0K
 
 
 
 
 
General Expenses25.4M26.8M26.6M23.0M
 
 
 
 
 
Research And Development21.5M22.7M21.4M19.7M
 
 
 
 
 
Total Operating Expenses25.4M27.2M26.6M23.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.4M-27.2M-25.8M-22.8M
 
 
 
 
 
Extraordinary Credit4.7M14.0M449.0K0.00
 
 
 
 
Extraordinary Charge-5.1M---17.2M-23.2M
 
 
 
 
Interest Expense On Debt33.0K271.0K570.0K793.0K
 
 
 
 
 
Other Expenses0.00-7.6M0.00349.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.9M-21.0M-42.7M-46.4M
 
 
 
 
 
Net Income-25.9M-21.0M-42.7M-46.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.4M60.6M65.7M69.4M
 
 
 
 
 
Shares To Calculate EPS Diluted57.4M60.6M65.7M69.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.45-$0.35-$0.65-$0.67
 
 
 
 
 
EPS Diluted-$0.45-$0.35-$0.65-$0.67
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account